Compounds specific to adenosine a1, a2a, and a3 receptor and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 5/46 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2430577

This invention pertains to compounds which specifically inhibit the adenosine A1, A2A, and A3 receptors and the use of these compounds to treat a disease associated with A1, A2A, and A3 adenosine receptors in a subjects, comprising administering to the subject a therapeutically effective amount of the compounds.

L'invention concerne des composés qui inhibent de manière spécifique les récepteurs de l'adénosine A¿1?, A¿2A?, et A¿3? et l'utilisation de ces composés pour traiter une maladie associées aux récepteurs de l'adénosine A¿1?, A¿2A?, et A¿3? chez un sujet, par administration à ce dernier d'une quantité efficace sur le plan thérapeutique desdits composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds specific to adenosine a1, a2a, and a3 receptor and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds specific to adenosine a1, a2a, and a3 receptor and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds specific to adenosine a1, a2a, and a3 receptor and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1912809

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.